Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and meta-analysis

被引：0
|
作者：
Chen Sun
Zheng Su
Yue-Ping Zeng
机构：
[1] Peking Union Medical College Hospital,Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
[3] National Clinical Research Center for Dermatologic and Immunologic Diseases,undefined
来源：
Inflammation Research | 2023年 / 72卷 / 9期
关键词：
Atopic dermatitis; Systemic JAK inhibitors; Acne; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1861 / 1871
页数：10
相关论文
共 50 条
  • [1] Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and meta-analysis
    Sun, Chen
    Su, Zheng
    Zeng, Yue-Ping
    [J]. INFLAMMATION RESEARCH, 2023, 72 (09) : 1861 - 1871
  • [2] Association of Risk of Incident Venous Thromboembolism With Atopic Dermatitis and Treatment With Janus Kinase Inhibitors A Systematic Review and Meta-analysis
    Chen, Tai-Li
    Lee, Ling-Ling
    Huang, Huei-Kai
    Chen, Li-Yu
    Loh, Ching-Hui
    Chi, Ching-Chi
    [J]. JAMA DERMATOLOGY, 2022, 158 (11) : 1254 - 1261
  • [3] Risk of incident venous thromboembolism associated with atopic dermatitis and treatment with janus kinase inhibitors: A systematic review and meta-analysis
    Chi, Ching-Chi
    Chen, Tai-Li
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 428 - 429
  • [4] The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (12) : 1923 - 1933
  • [5] The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis
    Carlos Alves
    Ana Penedones
    Diogo Mendes
    Francisco Batel Marques
    [J]. European Journal of Clinical Pharmacology, 2022, 78 : 1923 - 1933
  • [6] Efficacy and Safety of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
    Li, Chenyang
    Sun, Xun
    Zhao, Kun
    Meng, Fanxiang
    Li, Lin
    Mu, Zhenzhen
    Han, Xiuping
    [J]. DERMATOLOGY, 2022, 238 (04) : 725 - 735
  • [7] The risk of infections with janus kinase inhibitor treatment for atopic dermatitis: a systematic review and meta-analysis
    Tarafdar, N.
    Sachdeva, M.
    Dubale, N.
    Smythe, C.
    Lytvyn, Y.
    Maliyar, K.
    Georgakopoulos, J.
    Mufti, A.
    Yeung, J.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S338 - S338
  • [8] The effectiveness of Janus kinase inhibitors in treating atopic dermatitis: A systematic review and meta-analysis
    Arora, Charan Jeet
    Khattak, Fakhre Alam
    Yousafzai, Mohammad Tahir
    Ibitoye, Bukola Mary
    Shumack, Stephen
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [9] The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials
    Yoon, Sanghyuk
    Kim, Kihun
    Shin, Kihyuk
    Kim, Hoon-Soo
    Kim, Byungsoo
    Kim, Moon-Bum
    Ko, Hyun-Chang
    Kim, Yun Hak
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (01) : 52 - 61
  • [10] The efficacy of Janus kinase inhibitors in patients with atopic dermatitis: A systematic review and network meta-analysis
    Zhang, Lu
    Wang, Lian
    Jiang, Xian
    [J]. DERMATOLOGIC THERAPY, 2021, 34 (05)
12345